Lisinopril 10 mg Tablets Recalled for Metal Fragment Contamination
Evaric Pharmaceuticals is recalling Lisinopril 10 mg tablets after a metal fragment was found embedded in a tablet. The affected lot (241103) was distributed nationwide; contact your pharmacist if you have this medication.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: A metal fragment found in a prescription drug poses a risk of harm if ingested. This represents a 'risk-of-harm product where injury has not yet been reported,' meeting the rubric threshold for High severity despite the FDA Class II designation.
Plain-English summary
Evaric Pharmaceuticals Inc. is recalling Lisinopril 10 mg tablets due to discovery of a metal fragment embedded in a tablet. The recalled product is Lisinopril Tablets, USP 10 mg, packaged as 90-tablet bottles.
A pharmacist discovered a metal fragment in a tablet, which poses a risk of injury if ingested. This foreign object represents a significant contamination risk to patients who depend on this medication.
The recall affects Lot #241103 with an expiration date of 05/31/2026. Approximately 222,600 bottles were distributed nationwide. If you have this medication, contact your pharmacist or healthcare provider immediately. Do not take tablets from this lot. Return the medication to your pharmacy or dispose of it according to instructions from a healthcare professional.
The recalled product
- Product
- LISINOPRIL (LISINOPRIL)
- Brand
- LISINOPRIL
- Manufacturer
- Evaric Pharmaceuticals Inc.
- Category
- Drug
- Hazard
- foreign-object
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 241103
- exp. date 05/31/2026
UPCs (6)
- 0368645610900
- 0368645609904
- 0368645613901
- 0368645611907
- 0368645608907
- 0368645612904
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LISINOPRIL
- HighLisinopril Tablets Recalled for Embedded Metal Contamination
FDA (Drugs) · 2022-09-21
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27